Annual Immuno-Oncology Summit 2024
12th Annual Immuno-Oncology Summit | August 7-9, 2024 | Philadelphia, PA
The latest immuno-oncology developments will be covered in the conference programs. Bispecific Antibodies in Cancer Immunotherapy. CAR T therapy: Advances. Cancer vaccines that are therapeutic. New Technologies for IO Targeting & Discovery. Emerging cell-based immunotherapies. Tumor Microenvironment.
In the last 11 years, CHI’s Immuno-Oncology Summit is the leading annual meeting to advance biotherapeutics. This 3-day program includes six tracks that explore bi- and multifocal biotherapeutics, the latest advances in CAR-T therapies, new targeting technologies, cell-based immunotherapies, and personalized immunotherapy. It also addresses the challenges associated with overcoming tumor resistance. Participants will explore predictive models, modulation of the tumor microenvironment, and AI and machine-learning's increasing role in cancer immunology. The summit is a crucial platform for exchanging top-notch research and fostering collaborative efforts in the ever-evolving field of immuno-oncology.
Each year, more than 375 thought leaders and influentials from academia and industry converge on the event to present the latest advances in cancer immunology. The dynamic venue provides extensive networking opportunities and collaborations, empowering the teams to focus their objectives.
The 7th and 9th of August, we look forward to meeting you in Philadelphia, where we will be gathering to further our understanding of the immunosystem, propelling the next-generation of immunotherapies, to optimize patient outcomes.
Ji bo bilêtan an stendeyan qeyd bikin
Nexşeya Cihê û Otêlên Li Dorê
Boston - Boston, Massachusetts, USA Boston - Boston, Massachusetts, USA
Subscribe